miR-141 Contributes to Fetal Growth Restriction by Regulating PLAG1 Expression

PLoS ONE

Volumn 8, Issue 3, 2013, Pages

  Tang, Qiuqin ^a,b   Wu, Wei ^a,b,c   Xu, Xia ^a,b   Huang, Lu ^a   Gao, Qiong ^b   Chen, Huijuan ^a   Sun, Hong ^d   Xia, Yankai ^b,c   Sha, Jiahao ^b   Wang, Xinru ^b,c   Chen, Daozhen ^a   Xu, Qian ^a  

^a The Affiliated Wuxi Maternity and Child Health Care Hospital of Nanjing Medical University   (China)

^b NANJING MEDICAL UNIVERSITY   (China)

^c Nanjing Medical University   (China)

^d UNIVERSITY OF LEUVEN   (Belgium)

Author keywords

[No Author keywords available]

Indexed keywords

MICRORNA 141; PLACENTA PROTEIN; PLEIOMORPHIC ADENOMA GENE 1 PROTEIN; SOMATOMEDIN B; TRANSCRIPTION FACTOR E2F3; UNCLASSIFIED DRUG;

ADULT; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DOWN REGULATION; FEMALE; FETUS; GENE; GENE EXPRESSION REGULATION; GENE FUNCTION; GENE LOCATION; GENE TARGETING; GENETIC ASSOCIATION; HUMAN; HUMAN TISSUE; INTRAUTERINE GROWTH RETARDATION; PLACENTA; PLEIOMORPHIC ADENOMA GENE 1; PROTEIN EXPRESSION; REAL TIME POLYMERASE CHAIN REACTION; SENSITIVITY AND SPECIFICITY; UPREGULATION; WESTERN BLOTTING;

ADULT; DNA-BINDING PROTEINS; FEMALE; FETAL GROWTH RETARDATION; GENE EXPRESSION REGULATION; HUMANS; INSULIN-LIKE GROWTH FACTOR II; MICRORNAS; PLACENTA; PREGNANCY; RNA INTERFERENCE; ROC CURVE; YOUNG ADULT;

EID: 84875008642     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0058737     Document Type: Article

References (42)

1. Nardozza LM, Araujo Junior E, Barbosa MM, Caetano AC, Lee DJ, et al. (2012) Fetal growth restriction: current knowledge to the general Obs/Gyn. Arch Gynecol Obstet 286: 1-13.
2. Froen JF, Gardosi JO, Thurmann A, Francis A, Stray-Pedersen B, (2004) Restricted fetal growth in sudden intrauterine unexplained death. Acta Obstet Gynecol Scand 83: 801-807.
3. Barker DJ, Gluckman PD, Godfrey KM, Harding JE, Owens JA, et al. (1993) Fetal nutrition and cardiovascular disease in adult life. Lancet 341: 938-941.
4. Neerhof MG, (1995) Causes of intrauterine growth restriction. Clin Perinatol 22: 375-385.
5. Lin CC, Santolaya-Forgas J, (1998) Current concepts of fetal growth restriction: part I. Causes, classification, and pathophysiology. Obstet Gynecol 92: 1044-1055.
6. Abuzzahab MJ, Schneider A, Goddard A, Grigorescu F, Lautier C, et al. (2003) IGF-I receptor mutations resulting in intrauterine and postnatal growth retardation. N Engl J Med 349: 2211-2222.
7. Lee DH, Singh P, Tsark WM, Szabo PE, (2010) Complete biallelic insulation at the H19/Igf2 imprinting control region position results in fetal growth retardation and perinatal lethality. PLoS One 5: e12630.
8. Lieberman E, Gremy I, Lang JM, Cohen AP, (1994) Low birthweight at term and the timing of fetal exposure to maternal smoking. Am J Public Health 84: 1127-1131.
9. Vedmedovska N, Rezeberga D, Teibe U, Melderis I, Donders GG, (2011) Placental pathology in fetal growth restriction. Eur J Obstet Gynecol Reprod Biol 155: 36-40.
10. Mullins E, Prior T, Roberts I, Kumar S, (2012) Changes in the maternal cytokine profile in pregnancies complicated by fetal growth restriction. Am J Reprod Immunol 68: 1-7.
11. Maccani MA, Marsit CJ, (2009) Epigenetics in the placenta. Am J Reprod Immunol 62: 78-89.
12. Bushati N, Cohen SM, (2007) microRNA functions. Annu Rev Cell Dev Biol 23: 175-205.
13. Davis BN, Hata A, (2009) Regulation of MicroRNA Biogenesis: A miRiad of mechanisms. Cell Commun Signal 7: 18.
14. Kloosterman WP, Plasterk RH, (2006) The diverse functions of microRNAs in animal development and disease. Dev Cell 11: 441-450.
15. Gangaraju VK, Lin H, (2009) MicroRNAs: key regulators of stem cells. Nat Rev Mol Cell Biol 10: 116-125.
16. Gilad S, Meiri E, Yogev Y, Benjamin S, Lebanony D, et al. (2008) Serum microRNAs are promising novel biomarkers. PLoS One 3: e3148.
17. Pan Q, Chegini N, (2008) MicroRNA signature and regulatory functions in the endometrium during normal and disease states. Semin Reprod Med 26: 479-493.
18. Navarro A, Monzo M, (2010) MicroRNAs in human embryonic and cancer stem cells. Yonsei Med J 51: 622-632.
19. Hu Y, Li P, Hao S, Liu L, Zhao J, et al. (2009) Differential expression of microRNAs in the placentae of Chinese patients with severe pre-eclampsia. Clin Chem Lab Med 47: 923-929.
20. Hu M, Xia M, Chen X, Lin Z, Xu Y, et al. (2010) MicroRNA-141 regulates Smad interacting protein 1 (SIP1) and inhibits migration and invasion of colorectal cancer cells. Dig Dis Sci 55: 2365-2372.
21. Mitchell PS, Parkin RK, Kroh EM, Fritz BR, Wyman SK, et al. (2008) Circulating microRNAs as stable blood-based markers for cancer detection. Proc Natl Acad Sci U S A 105: 10513-10518.
22. Mouillet JF, Chu T, Hubel CA, Nelson DM, Parks WT, et al. (2010) The levels of hypoxia-regulated microRNAs in plasma of pregnant women with fetal growth restriction. Placenta 31: 781-784.
23. Smerieri A, Petraroli M, Ziveri MA, Volta C, Bernasconi S, et al. (2011) Effects of cord serum insulin, IGF-II, IGFBP-2, IL-6 and cortisol concentrations on human birth weight and length: pilot study. PLoS One 6: e29562.
24. Kusinski LC, Dilworth MR, Baker PN, Sibley CP, Wareing M, et al. (2011) System A activity and vascular function in the placental-specific Igf2 knockout mouse. Placenta 32: 871-876.
25. Randhawa R, Cohen P, (2005) The role of the insulin-like growth factor system in prenatal growth. Mol Genet Metab 86: 84-90.
26. Miura K, Miura S, Yamasaki K, Higashijima A, Kinoshita A, et al. (2010) Identification of pregnancy-associated microRNAs in maternal plasma. Clin Chem 56: 1767-1771.
27. Mayor-Lynn K, Toloubeydokhti T, Cruz AC, Chegini N, (2011) Expression profile of microRNAs and mRNAs in human placentas from pregnancies complicated by preeclampsia and preterm labor. Reprod Sci 18: 46-56.
28. Chim SS, Shing TK, Hung EC, Leung TY, Lau TK, et al. (2008) Detection and characterization of placental microRNAs in maternal plasma. Clin Chem 54: 482-490.
29. Ouseph MM, Li J, Chen HZ, Pecot T, Wenzel P, et al. (2012) Atypical E2F repressors and activators coordinate placental development. Dev Cell 22: 849-862.
30. Chong JL, Tsai SY, Sharma N, Opavsky R, Price R, et al. (2009) E2f3a and E2f3b contribute to the control of cell proliferation and mouse development. Mol Cell Biol 29: 414-424.
31. Parisi T, Yuan TL, Faust AM, Caron AM, Bronson R, et al. (2007) Selective requirements for E2f3 in the development and tumorigenicity of Rb-deficient chimeric tissues. Mol Cell Biol 27: 2283-2293.
32. Hensen K, Braem C, Declercq J, Van Dyck F, Dewerchin M, et al. (2004) Targeted disruption of the murine Plag1 proto-oncogene causes growth retardation and reduced fertility. Dev Growth Differ 46: 459-470.
33. Matsuyama A, Hisaoka M, Nagao Y, Hashimoto H, (2011) Aberrant PLAG1 expression in pleomorphic adenomas of the salivary gland: a molecular genetic and immunohistochemical study. Virchows Arch 458: 583-592.
34. Gisselsson D, Hibbard MK, Dal Cin P, Sciot R, Hsi BL, et al. (2001) PLAG1 alterations in lipoblastoma: involvement in varied mesenchymal cell types and evidence for alternative oncogenic mechanisms. Am J Pathol 159: 955-962.
35. Zatkova A, Rouillard JM, Hartmann W, Lamb BJ, Kuick R, et al. (2004) Amplification and overexpression of the IGF2 regulator PLAG1 in hepatoblastoma. Genes Chromosomes Cancer 39: 126-137.
36. Braem CV, Kas K, Meyen E, Debiec-Rychter M, Van De Ven WJ, et al. (2002) Identification of a karyopherin alpha 2 recognition site in PLAG1, which functions as a nuclear localization signal. J Biol Chem 277: 19673-19678.
37. Van Dyck F, Delvaux EL, Van de Ven WJ, Chavez MV, (2004) Repression of the Transactivating Capacity of the Oncoprotein PLAG1 by SUMOylation. J Biol Chem 279: 36121-36131.
38. Koukoura O, Sifakis S, Soufla G, Zaravinos A, Apostolidou S, et al. (2011) Loss of imprinting and aberrant methylation of IGF2 in placentas from pregnancies complicated with fetal growth restriction. Int J Mol Med 28: 481-487.
39. Johnson GL, Vaillancourt RR, (1994) Sequential protein kinase reactions controlling cell growth and differentiation. Curr Opin Cell Biol 6: 230-238.
40. Liu N, Enkemann SA, Liang P, Hersmus R, Zanazzi C, et al. (2010) Genome-wide gene expression profiling reveals aberrant MAPK and Wnt signaling pathways associated with early parthenogenesis. J Mol Cell Biol 2: 333-344.
41. Rossant J, Cross JC, (2001) Placental development: lessons from mouse mutants. Nat Rev Genet 2: 538-548.
42. Wodarz A, Nusse R, (1998) Mechanisms of Wnt signaling in development. Annu Rev Cell Dev Biol 14: 59-88.